Pharmaceutical Technology-10-02-2011

Pharmaceutical Technology

Pfizer Outlines Its Supply Strategy

October 02, 2011

Online Exclusives

35

10

John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.

Biotech Venture Funding Slips Below 2010 Levels

October 02, 2011

BioForum

35

10

Average deal size and amounts invested increased in the second quarter, but totals trail funding of last year.

Global Healthcare on the Ground: AAPS on Why Global HealthCare is Important Now

October 02, 2011

In the Field

35

10

AAPS Global Health Focus Group's Kishor M. Wasan discusses new initiatives.

Managing Business Risks During a Merger or Acquisition

October 02, 2011

Viewpoint

35

10

Getting the most value out of M&As requires proper upfront legwork.

Assessment of Large-Sample Unit-Dose Uniformity Tests

October 02, 2011

Peer-Reviewed Research

35

10

The authors describe the concept of the limiting discriminatory the limiting discriminatory threshold (LDT) as an objective means of evaluating the inherent quality requirement of a large-sample content-uniformity test.

Time is of the Essence

October 02, 2011

Agent-In-Place

35

10

Letting contamination build up can cause multiple headaches.

The Matrixx Zicam Verdict

October 02, 2011

Special Features

35

10

The authors summarize the Matrixx Initiatives, Inc. v. Siracusano case's implications for industry.

Pharmaceutical Technology, October 2011 Issue (PDF)

October 02, 2011

Issue PDF

35

10

Click the title above to open the Pharmaceutical Technology October 2011 issue in an interactive PDF format.